For those of you who perform your share of SCS trials, do you typically place 2 leads or 1 lead for your trials? I am speaking mainly about coverage for a FBSS patient with persistent back and bilateral lower extremity neuropathic pain.
In our fellowship, we always did 1-lead trials and frankly I thought they went pretty well. A lot of the guys around me in practice use 2 leads every time, but unless I can't achieve coverage with 1 lead I can't see a good reason to place 2.
Am I missing something (outside of the extra $ by not always placing 2)?
In our fellowship, we always did 1-lead trials and frankly I thought they went pretty well. A lot of the guys around me in practice use 2 leads every time, but unless I can't achieve coverage with 1 lead I can't see a good reason to place 2.
Am I missing something (outside of the extra $ by not always placing 2)?